Changes

no edit summary
Line 4: Line 4:  
{{Under Construction}}
 
{{Under Construction}}
   −
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-11-30. The original page can be found at [[HAEM4:Gamma Heavy Chain Disease]].
+
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:Gamma Heavy Chain Disease]].
 
}}</blockquote>
 
}}</blockquote>
 
==Primary Author(s)*==
 
==Primary Author(s)*==
Line 19: Line 19:  
==Cancer Category / Type==
 
==Cancer Category / Type==
   −
*[[Mature B-Cell Neoplasms]]
+
*[[HAEM4:Mature B-Cell Neoplasms]]
    
==Cancer Sub-Classification / Subtype==
 
==Cancer Sub-Classification / Subtype==
Line 355: Line 355:  
Some cases of gamma-HCD (γ-HCD) are concurrent with other lymphoid neoplasm have been reported in the literature and are listed below; treatment option varies with concurrent neoplasm
 
Some cases of gamma-HCD (γ-HCD) are concurrent with other lymphoid neoplasm have been reported in the literature and are listed below; treatment option varies with concurrent neoplasm
   −
*[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)]]
+
*[[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)]]
 
*DLBCL-diffuse large B cell Lymphoma
 
*DLBCL-diffuse large B cell Lymphoma
 
*LCPD-lymphoplasma cell proliferative disorder
 
*LCPD-lymphoplasma cell proliferative disorder
*[[Lymphoplasmacytic Lymphoma|Lymphoplasmacytic Lymphoma (LPL]])
+
*[[HAEM5:Lymphoplasmacytic lymphoma|Lymphoplasmacytic Lymphoma (LPL]])
 
*MALT -mucosa-associated lymphoid tissue
 
*MALT -mucosa-associated lymphoid tissue
 
*MDS-myelodysplastic syndrome
 
*MDS-myelodysplastic syndrome